Sai Capital closes trading window from Jul 01 until Q1FY27 results

0 min read     Updated on 18 Jun 2026, 12:26 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Sai Capital Ltd has shut its trading window from July 01, 2026, until the second trading day after Q1FY27 results are declared. The move complies with SEBI regulations and the company's internal code of conduct. The board meeting date for the results will be notified later.

powered bylight_fuzz_icon
43311357

*this image is generated using AI for illustrative purposes only.

Sai Capital Ltd has closed its trading window for designated persons and their immediate relatives effective July 01, 2026, to prevent insider trading ahead of its financial results announcement. The restriction remains in place until the second trading day following the declaration of the company's financial results for the first quarter of FY27 ending June 30, 2026. This measure aligns with the company’s Code of Conduct to Regulate, Monitor and Report Trading by Insiders and the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The Board of Directors will consider the financial results for the quarter, though the specific date of this meeting has not yet been announced. The company stated that the date would be intimated in due course. The trading window closure is a standard compliance mechanism to ensure that no insider trades occur while unpublished price-sensitive information is in possession of the designated persons.

The communication was addressed to BSE Limited’s Listing Department on June 18, 2026. Dr. Niraj Kumar Singh, Chairman and Managing Director, signed the disclosure on behalf of Sai Capital Ltd .

Historical Stock Returns for Sai Capital

1 Day5 Days1 Month6 Months1 Year5 Years
-2.26%+0.73%-3.72%-24.03%-38.67%+758.58%

When will the Board of Directors announce the specific date for the financial results meeting?

What are the market expectations for Sai Capital Ltd's Q1 FY27 financial performance?

How might the closure of the trading window impact the stock's liquidity ahead of the results?

Butterfly Ayurveda appoints Anjali Pattanayak as Company Secretary

1 min read     Updated on 28 May 2026, 08:01 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Butterfly Ayurveda Private Limited, a material subsidiary of Sai Capital, appointed Ms. Anjali Pattanayak as Company Secretary effective May 28, 2026. The board approved the appointment to bolster the subsidiary's governance. Ms. Pattanayak is an Associate Member of ICSI with expertise in corporate compliance.

powered bylight_fuzz_icon
41524249

*this image is generated using AI for illustrative purposes only.

Butterfly Ayurveda Private Limited, a material subsidiary of Sai Capital , appointed Ms. Anjali Pattanayak as Company Secretary and Key Managerial Personnel effective May 28, 2026. The appointment was approved by the board of directors of the subsidiary at a meeting held on the same day. This move strengthens the subsidiary's compliance and governance framework.

The appointment was intimated to the stock exchanges under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure references the SEBI Master Circular dated January 30, 2026.

Ms. Anjali Pattanayak is an Associate Member of the Institute of Company Secretaries of India (ICSI), holding membership number A75339. Her professional experience includes expertise in Secretarial Affairs, Corporate Governance, and Statutory Compliances.

Appointment Details

The specific details of the appointment are outlined below:

S. No Particulars Information
1. Reason for change Appointment of Ms. Anjali Pattanayak as Company Secretary (Key Managerial Personnel) of Butterfly Ayurveda Private Limited
2. Date of appointment May 28, 2026
3. Term of appointment Not Applicable
4. Brief Profile Associate Member of ICSI with experience in Secretarial Affairs, Corporate Governance, & Statutory Compliances

Historical Stock Returns for Sai Capital

1 Day5 Days1 Month6 Months1 Year5 Years
-2.26%+0.73%-3.72%-24.03%-38.67%+758.58%

How will this appointment influence Butterfly Ayurveda's strategic expansion plans over the next fiscal year?

What specific governance improvements are expected following Ms. Pattanayak's integration into the leadership team?

Could this move signal a potential initial public offering (IPO) for Butterfly Ayurveda in the near future?

More News on Sai Capital

1 Year Returns:-38.67%